Nan Shan Life Insurance related stories
All articles and analysis
GI 150: The leading allocators in private equityEven amid market turbulence and fears over returns, the LPs on the 2026 Global Investor 150 ranking show strong conviction in the asset class.
Why GP-led secondaries will gain traction in APAC this yearGP-led deals in the region remained a fraction of the global market in 2025.
Side Letter: Consolidating for survivalPrivate wealth and sovereign giants are having an outsized impact on alternatives consolidation. Plus: how firms should navigate 'reverse CFIUS'. Here's today's brief, for our valued subscribers only.
Side Letter: A year of distress?Rising default rates could hint at a wave of distressed opportunities. Plus: The exit outlook appears to be improving for climate assets; and another Taiwanese insurer hits the secondaries market. Here's today's brief, for our valued subscribers only.
CDIB raises $116mThe private equity arm of China Development Financial Holding Corporation has held a first close of global fund.
Nan Shan Life Insurance seeks 10-15 funds.The Taiwanese insurer gears up to expand the alternative investment exposure.
- Nan Shan Life is aiming at US and European investments
Nan Shan Life Insurance plans to commit to up to 20 investment funds.
- Taiwan’s Fubon Financial in RMB fund initiative
Fubon, which is partnering with China Development Bank and the Fujian provincial government, will reportedly raise RMB5bn for the fund.
- Primus Financial acquires US brokerage
The acquisition of Chapdelaine is the Hong Kong-based private equity start-up’s first since buying AIG's Nan Shan Insurance and will be a platform to build a global brokerage business.
- Financing finance
Despite the increased risks posed by investment in the financial services sector, recent deals show the crisis has failed to dampen private equity appetite for deals in this space. Yvette Choo reports.